Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZK-A03 in Herpes Zoster
NCT05806918Phase 3Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of interferon alfa-2b in herpes zoster (HZ), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
interferon alfa-2b
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05806918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806918.